bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: O S A J J M A M F J
2013: D N O

 
  Other news for:
Neoplasms
Fibrosis
Liver
 Resources from HONselect
Screening May Help Boost Liver Cancer Survival Rates
Simple tests for people with scarring of the liver spot tumors early, researchers report

By Robert Preidt

WEDNESDAY, May 7, 2014 (HealthDay News) -- Increased screening for liver tumors in people with cirrhosis -- scarring of the liver -- could help boost liver cancer survival rates, according to researchers.

A review of 47 studies that included more than 15,000 patients found the survival rate for those screened with ultrasound scans and blood tests was 51 percent, compared with a 28 percent rate for those who were not screened.

The research team, from the University of Texas Southwestern Medical Center, also found that cirrhosis patients who were screened were more likely to receive treatment for their cancer rather than end-of-life care.

"Curative therapies, such as surgery or a liver transplant, are only available if patients are found to have liver cancer at an early stage. Unfortunately, right now, only a minority of patients' cancers are found at an early stage," study author Dr. Amit Singal, medical director of the liver tumor clinic at UT Southwestern's Harold C. Simmons Cancer Center, said in a medical center news release.

Many cases of liver cancer can be caught early with screening, Singal noted.

"We have a simple test, an abdominal ultrasound, which is painless and easy, but we found that less than 20 percent of at-risk people have the test done, largely due to providers failing to order it," Singal said.

He hopes the findings, published recently in the online journal PLoS Medicine, will help persuade more cirrhosis patients and their doctors that screening is a good idea.

Liver cancer screening is not currently recommended by the U.S. Preventative Services Task Force, partly because no clinical trial has been conducted to assess its effectiveness, Singal noted.

Liver cancer is the third leading cause of cancer death worldwide. People with cirrhosis are at increased risk, and 3 to 5 percent of them develop liver cancer every year.

More information

The U.S. National Library of Medicine has more about cirrhosis.

SOURCE: University of Texas Southwestern Medical Center, news release, May 5, 2014

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=687545

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Neoplasms
Liver
Liver Neoplasms
Mass Screening
Survival Rate
Fibrosis
Research Personnel
Transplants
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact